The iTAP Study for Veterans
iTAP-V
The Impact of Insomnia Treatment on Heavy Alcohol Use Among Returning Veterans
2 other identifiers
interventional
71
1 country
1
Brief Summary
This project aims to evaluate improvement of insomnia as a mechanism of improvement in alcohol use outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2019
CompletedFirst Posted
Study publicly available on registry
January 15, 2019
CompletedStudy Start
First participant enrolled
April 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedResults Posted
Study results publicly available
January 15, 2025
CompletedJanuary 15, 2025
December 1, 2024
4.5 years
January 9, 2019
August 14, 2024
December 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Recruitment
Number of eligible participants who enrolled in the study
Assessed at baseline
Retention
Number of participants who complete all treatment sessions
Assessed at post-treatment (week 6)
Drinking Quantity
Assessed using Daily Drinking Questionnaire. Participants report the number of standard drinks consumed on each day of a typical week in the past month (on Monday, Tuesday, Wednesday, etc). Responses for each day are then summed to calculate a total "drinks per week" variable, where higher scores indicate more standard drinks.
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Alcohol-related Consequences
Assessed using the Brief Young Adult Alcohol Consequences Questionnaire, which asks participants to indicate (yes/no) which of 24 consequences they have experienced in the past month. Responses range from 0 to 24, with greater scores indicating more consequences.
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Insomnia Symptoms
Assessed using Insomnia Severity Index (ISI). ISI scores from 0 to 28, with higher scores indicating more severe insomnia.
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Sleep Quality
On daily sleep diaries, participants reported sleep quality on a scale from 0 (very poor) to 4 (very good). Higher scores indicate better sleep quality.
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Sleep Efficiency
Daily sleep diaries were used to calculate the amount of time that participants spent sleeping out of all the time they spent in bed. Values from 0 to 100, with higher scores indicating better sleep efficiency. The treatment goal is 85%.
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Client Satisfaction
Assessed using the 8-item Client Satisfaction Questionnaire. Participants rate their satisfaction with insomnia treatment on a scale from 1 (poor) to 4 (excellent). Scores were summed and then divided by the number of items to create a meaningful standardized score. Higher scores indicate greater satisfaction.
Mean score at post-treatment (week 6).
Secondary Outcomes (6)
Delay Discounting
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Negative Affect
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Emotion Regulation
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Alcohol Craving
Primary analyses will measure between-group change in at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
Percentage of Days Using Alcohol to Help With Sleep
Primary analyses will measure between-group change at post (week 6) and follow-up (week 20). Mean values at each time point are presented below.
- +1 more secondary outcomes
Study Arms (2)
CBT-I
EXPERIMENTALIndividual Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered once a week for six (6) weeks.
Sleep Hygiene
ACTIVE COMPARATORSleep hygiene handout delivered once to all participants.
Interventions
Cognitive Behavioral Therapy for Insomnia (CBT-I). Participants assigned to the CBT-I condition will attend 1-hour individual sessions of CBT-I once a week for five weeks. A sixth week of treatment will be included - and scheduled for the same date as the post-treatment assessment - if the participant and research team agree that it would be beneficial (e.g., if a participant has difficulty grasping cognitive therapy concepts). Consistent with clinical guidelines (Schutte-Rodin, Broch, Buysse, Dorsey, \& Sateia, 2008), treatment will include stimulus control (e.g., limit use of bed to sleep or sexual activity, get out of bed if lying awake for more than 20 minutes), sleep restriction (limit time in bed to amount of time spent sleeping on a typical night), sleep hygiene (e.g., avoid exercise within 2 hours of bedtime, create cool and dark sleep environment), relaxation training, and cognitive restructuring.
All participants will receive a one-page handout on sleep hygiene that includes personalized normative feedback on their alcohol use. This is the only intervention that participants assigned to the Sleep Hygiene condition will receive and is consistent with what may be expected as standard care in a doctor's visit with a primary care physician.
Eligibility Criteria
You may qualify if:
- Veteran deployed for military service after September 11, 2001
- + heavy drinking episode (4/5+ drinks in 2 hours for women/men) in past 30 days
- DSM-5 and research diagnostic criteria for Insomnia Disorder
You may not qualify if:
- Inability to provide informed consent
- Cognitive impairment
- Contraindications for CBT-I (mania or seizure disorder)
- Untreated sleep disorder requiring more than behavioral treatment for insomnia
- Engagement in overnight shift work at baseline
- Care of a child under 1 year of age
- Severe or untreated psychiatric disorder that requires immediate clinical attention
- Current behavioral treatment for insomnia or alcohol use
- Initiation of sleep medication in the past 6 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri-Columbia
Columbia, Missouri, 65212, United States
Related Publications (1)
Miller MB, Carpenter RW, Shoemaker SD, Moskal KR, Borsari B, Pedersen ER, Bartholow BD, Steinley D, McCrae CS. Cognitive behavioral therapy for insomnia among heavy-drinking veterans: a randomized pilot trial. Sleep Adv. 2025 Jun 10;6(2):zpaf037. doi: 10.1093/sleepadvances/zpaf037. eCollection 2025 Apr.
PMID: 40575624DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The COVID-19 pandemic changed the way people drink and required modifications to the protocol. Most treatment sessions were conducted via telehealth. As a result, all data were collected via self-report. Finally, data were collected from a relatively small, homogeneous sample of heavy-drinking Veterans. The control condition was not matched with CBT-I for time and content, so we cannot determine from this trial whether improvements are due to CBT-I or non-specific therapy effects.
Results Point of Contact
- Title
- Dr. Mary Beth Miller
- Organization
- University of Missouri
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- PI Miller will be blind to participant assignment because the project manager will inform study therapists of participant assignment to conditions. PI Miller and study therapists will be blinded to assessment outcomes, and assessment RAs will be blinded to participant condition. All participants will be told that they are receiving treatment for insomnia in order to blind them to condition assignment (sleep hygiene will be described as "brief" insomnia treatment, and CBT-I will be described as the "most intense" treatment).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Psychiatry
Study Record Dates
First Submitted
January 9, 2019
First Posted
January 15, 2019
Study Start
April 4, 2019
Primary Completion
September 30, 2023
Study Completion
September 30, 2023
Last Updated
January 15, 2025
Results First Posted
January 15, 2025
Record last verified: 2024-12